MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1872-034x.2010.00640.x

Медицинская библиотека · Hepatology research : the official journal of the Japan Society of Hepatology · 2010

Effect of chronic methylene blue administration on hypoxemia in rats with common bile duct ligation.

Miyamoto Akiko, Katsuta Yasumi, Zhang Xue-Jun, Li Hong-Li, Ohsuga Masaru, Komeichi Hirokazu, Shimizu Shuji, Akimoto Toshio, Mizuno Kyoichi

СтатьяПеревод пока не подготовлен

Аннотация

AIM: Acute administration of methylene blue (MB) can reverse hypoxemia in patients with hepatopulmonary syndrome (HPS). We evaluated the effect of chronic MB administration in common bile duct-ligated rats, which develop HPS by 5 weeks after surgery.

METHODS

A total of 96 Sprague-Dawley rats were used, including 63 rats with common bile duct ligation (CBDL), 22 sham-operated rats and 11 normal control rats. MB (6 mg/kg) was injected s.c. once a day for 4 weeks. Evaluation of hemodynamics and intrapulmonary vascular dilatation (IPVD), as well as blood sampling for arterial blood gas analysis, were done under conscious and unrestrained conditions. Hemodynamics were assessed by the reference sample method using (141)Ce-microspheres (15 microm in diameter), and IPVD was also determined by i.v. injection of these microspheres. Histological examination of the lungs was done with hematoxylin-eosin staining and immunohistochemical staining for von Willebrand factor or vascular endothelial growth factor.

RESULTS

Both the arterial oxygen tension and alveolar-arterial oxygen difference were significantly improved in MB-treated CBDL rats. The hyperdynamic circulation and splanchnic hyperemia seen in untreated CBDL rats were also alleviated by MB treatment. However, IPVD was not affected by MB. Histological examination of the lungs indicated that MB treatment reduced the proliferation of alveolar capillary vessels and angiogenesis, leading to improvement of arterial dysoxygenation. Hepatic synthetic and detoxification functions, as well as renal function, were not altered by MB treatment.

CONCLUSION

Methylene blue may be a candidate treatment for HPS that does not cause deterioration of hepatic or renal function.

Для цитирования: Miyamoto Akiko, Katsuta Yasumi, Zhang Xue-Jun, Li Hong-Li, Ohsuga Masaru, Komeichi Hirokazu, Shimizu Shuji, Akimoto Toshio, Mizuno Kyoichi. Effect of chronic methylene blue administration on hypoxemia in rats with common bile duct ligation.. Hepatology research : the official journal of the Japan Society of Hepatology. 2010. DOI: 10.1111/j.1872-034x.2010.00640.x.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.